OP0286 The utility of the omeract ultrasound tenosynovitis scoring system in multicenter clinical trials

M Ammitzbøll-Danielsen; M Østergaard; N Esperanza; A Iagnocco; I Möller; M-A D'Agostino; F Gandjbakhch; L Terslev

doi:10.1136/annrheumdis-2017-eular.1651

OP0286 The utility of the omeract ultrasound tenosynovitis scoring system in multicenter clinical trials

M Ammitzbøll-Danielsen
, M Østergaard
, N Esperanza
, A Iagnocco
, I Möller
, M-A D'Agostino
, F Gandjbakhch
, L Terslev

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	76
Udgave nummer	Suppl 2
Sider (fra-til)	174-175
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2017-eular.1651
Status	Udgivet - 2017

Adgang til dokumentet

10.1136/annrheumdis-2017-eular.1651

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{e5d68fcfb65443568567b29d3f128deb,

title = "OP0286 The utility of the omeract ultrasound tenosynovitis scoring system in multicenter clinical trials",

author = "M Ammitzb{\o}ll-Danielsen and M {\O}stergaard and N Esperanza and A Iagnocco and I M{\"o}ller and M-A D'Agostino and F Gandjbakhch and L Terslev",

year = "2017",

doi = "10.1136/annrheumdis-2017-eular.1651",

language = "English",

volume = "76",

pages = "174--175",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "Suppl 2",

}

TY - ABST

T1 - OP0286 The utility of the omeract ultrasound tenosynovitis scoring system in multicenter clinical trials

AU - Ammitzbøll-Danielsen, M

AU - Østergaard, M

AU - Esperanza, N

AU - Iagnocco, A

AU - Möller, I

AU - D'Agostino, M-A

AU - Gandjbakhch, F

AU - Terslev, L

PY - 2017

Y1 - 2017

U2 - 10.1136/annrheumdis-2017-eular.1651

DO - 10.1136/annrheumdis-2017-eular.1651

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 174

EP - 175

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

ER -